Arno Therapeutics, Inc.
ARNI - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.94K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $4,935.00 |
|---|---|
| Enterprise Value | $-2,114,056.00 |
| Earnings per Share | $-0.57 |
| Beta | 1.55 |
| Outstanding Shares | 44,705,825 |
Return
| Return on Equity | 240.41% |
|---|---|
| Return on Assets | -583.19% |
| Return on Invested Capital | -1648.57% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.15 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Arno Therapeutics, Inc.
4 employees
CEO: David M. Tanen
Arno Therapeutics, Inc., headquartered in Flemington, New Jersey, operates as a biopharmaceutical enterprise focused on discovering and advancing treatments for cancer and other severe health conditions. The company's developmental portf...